Rikkunshito improves symptoms in PPI-refractory GERD patients: A prospective, randomized, multicenter trial in Japan

Journal of Gastroenterology

Volumn 47, Issue 3, 2012, Pages 284-292

  Tominaga, Kazunari ^a   Iwakiri, Ryuichi ^b   Fujimoto, Kazuma ^b   Fujiwara, Yasuhiro ^a   Tanaka, Mio ^b   Shimoyama, Yasuyuki ^c   Umegaki, Eiji ^d   Higuchi, Kazuhide ^d   Kusano, Motoyasu ^c   Arakawa, Tetsuo ^a  

^a Osaka Prefecture University   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY HOSPITAL   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Abdominal discomfort; Acid suppressive therapy; Heartburn; Rikkunshito

Indexed keywords

HERBACEOUS AGENT; RABEPRAZOLE; RIKKUNSHITO; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGE; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FREQUENCY SCALE FOR THE SYMPTOMS OF GASTROESOPHAGEL REFLUX DISEASE; GASTROESOPHAGEAL REFLUX; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; JAPAN; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84863108080     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0488-5     Document Type: Article

References (33)

1. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Strategy for treatment of nonerosive reflux disease in Asia. World J Gastroenterol. 2008;14:3123-8.
2. Vakil N, van Zanten SV, Kahrialis P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-20.
3. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in Grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997;112:1798-810. (Pubitemid 27240763)
4. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: protonpump inhibitor failure in gastro-oesophageal reflux disease. Where next? Aliment Pharmacol Ther. 2005;22:79-94. (Pubitemid 41039696)
5. Hershcovici T, Fass R. Nonerosive reflux disease (NERD) - an update. J Neurogastroenterol Motil. 2010;16:8-21.
6. Holloway RH, Dent J, Narielval F, Mackinnon AM. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut. 1996;38:649-54. (Pubitemid 26167469)
7. Coté GA, Howden CW. Potential adverse effects of proton pump inhibitors. Curr Gastroenterol Rep. 2008;10:208-14.
8. Futagami S, Iwakiri K, Shindo T, Kawagoe T, Horie A, Shimpuku M, et al. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol. 2010;45:413-21.
9. Kawahara H, Kubota A, Hasegawa T, Okuyama H, Ueno T, Ida S, et al. Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int. 2007;23:1001-5. (Pubitemid 47437358)
10. Hayakawa T, Arakawa T, Kase Y, Akiyama S, Ishige A, Takeda S, et al. Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res. 1999;25:211-8. (Pubitemid 29497741)
11. Kido T, Nakai Y, Kase Y, Sakakibara I, Nomura M, Takeda S, et al. Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine. J Pharmacol Sci. 2005;98:161-7. (Pubitemid 40943722)
12. Tominaga K, Kido T, Ochi M, Sadakane C, Mase A, Okazaki H, et al. The traditional Japanese medicine rikkunshito promotes gastric emptying via the antagonistic action of the 5-HT3 receptor pathway in rats. eCAM 2009:1-8. doi:10.1093/ecam/nep173.
13. Hattori T, Fujitsuka N, Asakawa A, Inui A. A strategy using rikkunshito (Liu-Jun-Zi-Tang), a Japanese traditional medicine, to treat gastrointestinal disease. In: Satoh H, editor. Basics of evidences-based herbal medicine. Kerala: Research Signpost; 2010. p. 149-60.
14. Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Development and evaluation of FSSG; frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888-91. (Pubitemid 39409671)
15. Kusano M, Shimoyama Y, Kawamura O, Maeda M, Kuribayashi S, Nagoshi A, et al. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Dig Dis Sci. 2007;52:1673-7. (Pubitemid 46870568)
16. Pehlivanov N, Liu J, Mittal R. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Gastroenterol. 2001;281:743-51.
17. Xenos ES. The role of esophageal motility and hiatal hernia in esophageal exposure to acid. Surg Endosc. 2002;16:914-20. (Pubitemid 34591993)
18. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003;17:243-51. (Pubitemid 36174255)
19. Fass R, Naliboff B, Higa L, Johnson C, Kodner A, Munakata J, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 1998;115:1363-73. (Pubitemid 28545986)
20. Sifrim D, Mittal R, Fass R, Smout A, Castell D, Tack J, et al. Acidity and volume of the refluxate in the genesis of gastrooesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007;25:1003-15. (Pubitemid 46587688)
21. Miwa H, Minoo T, Hojo M, Yaginura R, Nagahara A, Kawabe M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20:112-7. (Pubitemid 39120282)
22. Kawahara H, Mitani Y, Nomura M, Nose K, Yoneda A, Hasegawa T, et al. Impact of rikkunshito, an herbal medicine, on delayed gastric emptying in profoundly handicapped patients. Pediatr Surg Int. 2009;25:978-90.
23. Tatsuta M, Iishi H. Effect of treatment with Lui-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther. 1993;7:459-62. (Pubitemid 23267023)
24. Kusunoki H, Haruma K, Hata J, Ishii M, Kamada T, Yamashita N. Efficacy of rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med. 2010;49: 2195-202.
25. Tomono H, Ito Y, Watanabe T. Successful antiemetics treatment of TSUMURA rikkunshito extract granules for ethical use in addition to other antiemetics agents in neoadjuvant chemotherapy for an advanced breast cancer patient (in Japanese with English abstract). Jpn J Cancer Chemother. 2006;33:1129-31.
26. Takahashi T, Endo S, Nakajima K, Souma Y, Nishida T. Effect of rikkunshito, a Chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy. World J Surg. 2009;33:296-302.
27. Matsumura T, Arai M, Yonemitsu Y, Maruoka D, Tanaka T, Suzuki T, et al. The traditional Japanese medicine rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol. 2010;45:300-7.
28. Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134:2004-13. (Pubitemid 351783256)
29. Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, et al. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology. 2010;151:3773-82.
30. Kamiya T, Adachi H, Hirako M, Shikano M, Matsuhira E, Wada T, et al. Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease. J Gastroenterol. 2009;44:183-9.
31. Ruth M, Hamelin B, Röhss K, Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998;12:35-40. (Pubitemid 28057402)
32. Kim YS, Kim TH, Choi CS, Shon YW, Kim SW, Seo GS, et al. Effect of itopride, a new prokinetic, in patients with mild GERD: A pilot study. World J Gastroenterol. 2005;22:4210-4. (Pubitemid 41086873)
33. Miwa H, Koseki J, Oshima T, Kondo T, Tomita T, Watari J, et al. Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J Gastroenterol. 2010;45:478-87.